A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Cardinal Health Selected by the Ohio Department of Health for COVID-19 Vaccine Distribution

Cardinal Health has been selected by the Ohio Department of Health to support its efforts to distribute COVID-19 vaccines by arranging transportation within the state of Ohio.

Once a vaccine is available and Ohio receives doses for in-state distribution, Cardinal Health’s OptiFreight® Logistics* business will provide same-day delivery services to approximately 350 locations across 88 counties.

The state of Ohio currently expects initial vaccine doses to require special handling and temperature control, and OptiFreight® Logistics will leverage its expertise in managing the transportation of sensitive products to ensure safe, successful delivery.

“We are proud to provide our services to support our home state,” said Steve Mason, CEO of Medical segment, Cardinal Health. “A fully coordinated supply chain is critical to getting Americans safely vaccinated, and Cardinal Health is uniquely positioned to support Ohio’s vaccination efforts so we can collectively begin to put COVID-19 behind us.”

*A division of Cardinal Health, OptiFreight® Logistics provides freight management across the continuum of care, delivering total transportation management for the healthcare industry. As a premier comprehensive logistics management provider, OptiFreight® Logistics anticipates healthcare customers’ needs to help them optimize shipping costs through advanced analytics and integrated shipping solutions

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The company announced the launch of validated antibodies for rare cell and circulating tumor cell (CTC) enumeration. Validated for use with Bio-Rad’s Celselect Slides Enumeration Stain Kits, the antibodies are specific to CTC surface markers to enable the sensitive and specific identification of target cell populations, enhancing the study of tumor heterogeneity and disease progression at various stages.
Proteintech advises the new building houses research and development, production, logistics and administration in an area more than three times larger than its previous space.
In September 2023, Seegene and Springer Nature opened applications to scientists and experts across the global community to conduct research for the 15 designated projects to develop Seegene's syndromic qPCR diagnostics assay reagents for the Open Innovation Program.
Lindus Health has taken learnings from this experience to build a bespoke "All-in-One Metabolic CRO" offering that combines the expertise of a seasoned full service CRO and internal site/PI expertise with a distinctive technology driven approach on its proprietary Citrusâ„¢ platform. This unique marriage of technology and services sets metabolic sponsors up to run faster, more patient-centric clinical trials.
The addition of Olink to the Synexa Life Sciences technology portfolio demonstrates our continued commitment to strengthening our biomarker and bioanalysis capabilities across several expertise areas including oncology, immuno-oncology, infectious diseases and more.

By using this website you agree to accept Medical Device News Magazine Privacy Policy